tbuckley/cabot-search huggingface dataset:
Effects of Intravenous Immunoglobulin Supplementation (IVIG) on Infections in Recipients of Teclistamab Therapy for Multiple Myeloma (MM): A Multi-Institutional Study
Authors: Heloise Cheruvalath, Anna Clennon, Asis Shrestha, Aniko Szabo, Vineel Bhatlapenumarthi, Anannya Patwari, Metodi Balev, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Anup Kumar Trikannad, Sruthi Vellanki, Samer Al Hadidi, Suzanne Lentzsch, Frits van Rhee, Mansi R. Shah, Aishee Bag, Anita D'Souza, Rajshekhar Chakraborty, Nishi Shah, Carolina Schinke, Meera Mohan
Journal: Blood (2024)
Iopofosine I 131 in Previously Treated Patients with Waldenström Macroglobulinemia (WM): Efficacy and Safety Results from the International, Multicenter, Open-Label Phase 2 Study (CLOVER-WaM™)
Authors: Sikander Ailawadhi, Maria Gavriatopoulou, Jennifer Peterson, Ioannis Ntanasis-Stathopoulos, Ghassan El-Haddad, Ariel Grajales-Cruz, Aimaz Afrough, Moshe Y. Levy, Judith Trotman, Kimberly R. Doucette, Jorge J. Castillo, Francisco Hernandez-Ilizaliturri, Ajay K. Nooka, Shirley D'Sa, Ralph V. Boccia, Harsh Parmar, Carlos Fernández de Larrea, Guldane Cengiz Seval, Luiza Beatriz Goncalves Beber, Radhakrishnan Ramchandren, Sheeba K. Thomas, Jarrod Longcor, Andrei Shustov, Larry D Anderson
Journal: Blood (2024)
Drug Sensitivity and Treatment Response Are Modulated By the Cell of Origin, the Underlying Gene Fusion, and Patient Age in <i>KMT2A</i>-Rearranged BCP-ALL
Authors: Alina M. Hartmann, Lorenz Bastian, Malwine J Barz, Eric Amelunxen, Johannes Haas, Lennart Lenk, Michaela Kotrova, Thomas Beder, Fabio D. Steffen, Kerstin K. Rauwolf, Nadine Wolgast, Patrick Ehm, Sonja Bendig, Julia Alten, Mayukh Mondal, Aeint-Steffen Ströh, Thomas Burmeister, Nicola Goekbuget, Beat Bornhauser, Jean-Pierre Bourquin, Monika Brüggemann, Martin Schrappe, Gunnar Cario, Claudia D Baldus
Journal: Blood (2024)
Avespa Study: Effectiveness and Safety of Avatrombopag in Immune Thrombocytopenia (ITP). a Real-World Study of the Spanish ITP Group (GEPTI)
Authors: Maria Cristina Pascual Izquierdo, Blanca Sanchez Gonzalez, Mariana Canaro Hinryk, Gloria García-Donas Gabaldón, María Menor Gómez, Juan Jose Gil Fernandez, Silvia Monsalvo Saornil, Maria Teresa Alvarez Roman, Isidro Jarque, María José Llácer Ferrandis, Denis Zafra, Isabel Caparros Miranda, Ariana Ortúzar Pasalodos, Nuria Revilla, Jose Maria Bastida Bermejo, Montserrat Alvarellos Outeiro, Reyes Jimenez Barcenas, Silvia Bernat Bernat, Esther Chica Gullón, Daniel Martinez Carballeira, Sunil Lakhwani, Elsa Lopez Ansoar, Esperanza Moreno Beltran, Alvaro Lorenzo Vizcaya, Marta Canet Maldonado, Isabel Gonzalez y Gascon, Gonzalo Caballero Navarro, Amalia Cuesta, Begoña Pedrote, Maria Aranzazu Aguirre Arrizabalaga, Maialen Lasa Eguialde, Marta Moreno Carbonell, Alicia Ortiz López, Eva Mingot Castellano
Journal: Blood (2024)
Preliminary Efficacy and Safety of the Bruton Tyrosine Kinase Degrader BGB-16673 in Patients with Relapsed or Refractory Waldenström Macroglobulinemia: Results from the Phase 1 CaDAnCe-101 Study
Authors: John F. Seymour, Constantine S. Tam, Chan Y. Cheah, Ricardo D. Parrondo, John N. Allan, Judith Trotman, Ranjana H. Advani, Herbert A. Eradat, Pier Luigi Zinzani, Masa Lasica, Steven P. Treon, Xiangmei Chen, Kunthel By, Shannon Fabre, Daniel O. Persky, Amit Agarwal, Anna Maria Frustaci
Journal: Blood (2024)
Efficacy and Safety of Isatuximab, Pomalidomide and Dexamethasone in Relapsed AL Amyloidosis: Interim Results of the Isamyp Phase 2 Joint Study from the IFM and ALLG
Authors: Peter Mollee, Antoine Huart, Olga Mortona, Kentin Queru, Cecile Leyronnas, Harel Stephanie, Hasib Sidiqi, Estelle Desport, Laure Vincent, Margaret Macro, Salomon Manier, Caroline Jacquet, Pierre Morel, Noemi Horvath, Sebastien Bender, Guillaume Olombel, Virginie Pascal, Jill Corre, Frank Bridoux, Arnaud Jaccard, Murielle Roussel
Journal: Blood (2024)
Dynamics of Oligoclonal Hematopoiesis in Severe Aplastic Anemia Patients Undergoing Immunosuppressive Treatment: Longitudinal Somatic Mutation Analysis from the EBMT Race Trial
Authors: Denise Kaya, Riley Cook, Simona Iacobelli, Austin G. Kulasekararaj, Giorgio Napolitani, Sila Gerlevik, Nogayhan Seymen, Flore Sicre de Fontbrune, Morag Griffin, Camilla Frieri, Constantijn J.M. Halkes, Christian Recher, Fiorenza Barraco, Edouard Forcade, Jean-Baptiste Méar, Marica Laurino, Beatrice Drexler, Etienne Daguindau, Marleen Van Os, Sofie Terwel, Carlo Dufour, Mohammad M. Karimi, Regis Peffault De Latour, Antonio M Risitano, Ghulam Mufti
Journal: Blood (2024)
Early Initiation of Calcineurin Inhibitor Induces CD8+ Transitory Exhausted-like and CD4+ Cytotoxic T Cells, Maintaining Responsiveness to PD-1 Blockade and Contributing to the Development of Chronic Gvhd after Post-Transplant Cyclophosphamide
Authors: Hajime Senjo, Daigo Hashimoto, Shihori Tsukamoto, Keisuke Kojima, Shimpei I Kubota, Ayumu Ito, Tomoe Ichiki, Satomi Okada, Yumika Saito, Toru Miyajima, Shinpei Harada, Wenyu Li, Zixuan Zhang, Yuta Hasegawa, Hiroyuki Ohigashi, Takahide Ara, Yoshinori Hasegawa, Yoshihiro Inamoto, Masaaki Murakami, Takahiro Fukuda, Takanori Teshima
Journal: Blood (2024)
Pharmacokinetic-Guided Reduction of Emicizumab in Patients with Congenital Hemophilia a in the Netherlands: Interim Analysis from the Dosemi Study
Authors: Konrad Van Der Zwet, Marjon H. Cnossen, Floor CJI Moenen, Saskia EM Schols, Paula F Ypma, Paul L. den Exter, Louise Hooimeijer, Michiel Coppens, Ron A.A. Mathôt, Anouk A.M.T. Donners, Alexander Janssen, Ilmar Kruis, Eduard J. Van Beers, Corien L. Eckhardt, Rolf T. Urbanus, Lize Fie Ditteke Van Vulpen, Roger EG Schutgens, Kathelijn Fischer
Journal: Blood (2024)
CDK8 Inhibition Represses Monocyte-like Gene Expression in Acute Myeloid Leukemia Cells and Antagonizes In Vivo Resistance to FLT3 Inhibition
Authors: Timothy T. Ferng, Samantha M. Pintar, Vanessa E. Kennedy, Shaheen Kabir, Theodore C. Tarver, Veronica Steri, Paul Phojanakong, Juwita Hübner, Carolina E. Morales, Jose M. Rivera, Aaron C. Logan, Benjamin Braun, Elliot Stieglitz, Luke A. Gilbert, Catherine C. Smith
Journal: Blood (2024)
Creation of a Multistate Model to Improve Prognostication across the Disease Course in Advanced Stage Classic Hodgkin Lymphoma (cHL): A Report from the Holistic Consortium
Authors: Angie Mae Rodday, Susan K. Parsons, Zhu J Cui, Qingyan Xiang, Nicholas Counsell, Sara Rossetti, Jenica N Upshaw, Annalynn M Williams, Amy A Kirkwood, Hongli Li, James R. Cerhan, Massimo Federico, Jonathan W. Friedberg, Andrea Gallamini, Eliza A. Hawkes, David Hodgson, Martin Hutchings, Peter Johnson, Brian K. Link, Eric Mou, John Radford, Kerry J. Savage, Deborah M. Stephens, Pier Luigi Zinzani, Matthew J. Maurer, Andrew M Evens
Journal: Blood (2024)
Prediction of Post-Transplant Relapse of the Myelodysplastic Syndromes Via Evaluation of Stem Cells
Authors: Benjamin Kroger, Roni Tamari, Carmelo Gurnari, Julio Alvarenga Thiebaud, Alejandro Marinos Velarde, Yazan F Madanat, Robert H. Collins, Clayton Jackson, Vivian Irizarry Gatell, Valeria Visconte, Jaroslaw Maciejewski, David Sallman, Stephen Chung
Journal: Blood (2024)
Outpatient Hematopoietic Stem Cell Transplant for Adult Sickle Cell Disease Patients Is Safe, Reduce Inpatient Bed Utilization and Improve Access to Care
Authors: Mohsen Alzahrani, Ahmed Alaskar, Ayman Alhejazi, Abdullah Alsaleh, Husam Mazin Alsadi, Mazin Mohamed Abdulsalam, Mohammed Bakkar, Khalid Alharbi, Hind Salama, Abdulrahman Al Raizah, Ayman Ibrahim, Ayel Yahya, Khalid Aldosari, Sumaya Altamimi, Abdul Rauf Ghori, Nour Ibrahim, Usman Maitla, Naveed Qureshi, Mohammed Snnallah, Inaam Shehabeddine, Tahani Alanazi, Rasha Ahmed, Amani Alharbi, Suha Alkhraisat, Isam Mahasneh, Hamza Alquraan, Afnan Alzaidi, Eman Anizi, Norah Alshuraym, Maybelle Ballili, Bader Alahmari
Journal: Blood (2024)
SAGES1: Clinical Translation of CRISPR Genome Editing Strategy to Induce Fetal Hemoglobin to Treat Sickle Cell Disease
Authors: Rachel M Levine, Erin A Dempsey, Nikitha Nimmagadda, Yoonjeong Jang, Kalin Mayberry, Jingjing Zhang, David Cullins, Catherine Willis, Alicia Powers, Young-In Kim-Hoehammer, Jie Lin, Fei Zhang, Neha Das Gupta, Will Lewis, Varun Katta, Yichao Li, Timothy Lockey, Yong Cheng, Patti Lehigh, Frank Fazio, Alexis Kristine Leonard, Akshay Sharma, Sheng Zhou, Shengdar Q Tsai, Mitchell J Weiss, Jonathan S Yen
Journal: Blood (2024)
Orally Bioavailable CDK9 Inhibitor Voruciclib Downregulates Oncogenic Pathways in Leukemic Cells from Patients Treated on a Clinical Trial
Authors: Edward C. Dominguez, Carly Roleder, Canping Chen, Zheng Xia, Sandra Wiley, Matthew S. Davids, Alexey Danilov
Journal: Blood (2024)
Platelets-Derived Integrin and Tetraspanin-Rich Tethers (PITTs) Drive Pulmonary Inflammation
Authors: Christian Hackenbroch, Charly Kusch, Denise Johnson, Paquita Nurden, Carina Gross, Philipp Burkard, Lukas Johannes Weiss, Markus Sauer, Harald Schulze, Alan T. Nurden, David Stegner, Bernhard Nieswandt
Journal: Blood (2024)
TP53 Mutations within T Cells Induce T-Cell Exhaustion and Functional Impairment in TP53 Mutant AML
Authors: Li Li, Muharrem Muftuoglu, Edward Ayoub, Aram Bidikian, Prashant Menon, Jiangxing Lv, Mahesh Basyal, Andrea Bedoy, Anudishi Tyagi, Amanda Eckstrom, Venkata Lokesh Battula, Navin Varadarajan, Ghayas C. Issa, Michael Andreeff
Journal: Blood (2024)
Multiomic Analyses Uncover Immune Signatures of Steroid-Refractory Graft-Versus-Host Disease
Authors: Zengkai Pan, Yujun Deng, Jingtao Huang, Aijie Huang, Xiong Ni, Lei Gao, Chuanhe Jiang, Luxiang Wang, Zilu Zhang, Quan Gu, Hui Cheng, Jianmin Wang, Hongbo Hu, Xiaoxia Hu
Journal: Blood (2024)
Outcomes of Autologous Stem Cell Transplant in Older Adults with Relapsed/Refractory Classic Hodgkin Lymphoma
Authors: Sanjal H. Desai, Michael A Spinner, Alice Sykorova, Veronika Bachanova, Andrew M Evens, Gaurav Goyal, Brad S. Kahl, Kathleen Dorritie, Jacques Azzi, Vaishalee P Kenkre, Cheryl Chang, Jozef Michalka, Stephen M. Ansell, Brendon Fusco, Nuttavut Sumransub, Haris Hatic, Raya Saba, Uroosa Ibrahim, Elyse I Harris, Harsh R. Shah, Nina Wagner-Johnston, Sally Arai, Grzegorz S. Nowakowski, Heidi Mocikova, Deepa Jagadeesh, Kristie A. Blum, Catherine S. Diefenbach, Siddharth Iyengar, K. C. Rappazzo, Firas Baidoun, Yun Choi, Vit Prochazka, Ranjana H. Advani, Ivana N. Micallef
Journal: Blood (2024)
Efficacy and Safety of Odronextamab in Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL): Data from the R/R MZL Cohort in the ELM-2 Study
Authors: Tae Min Kim, Seok-Goo Cho, Michal Taszner, Geoffrey Chong, Jingxian Cai, Amulya Uppala, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, John N. Allan
Journal: Blood (2024)
Decitabine Plus All-<i>Trans</i> Retinoic Acid Versus Decitabine Monotherapy for Myelodysplastic Syndromes with Excess Blasts: A Multicentre, Randomized Controlled Trial
Authors: Hongyan Tong, Xinping Zhou, Yanjuan Lin, Yan Gao, Zheng Ge, Huang Li, Jin Zhang, Hai Cheng, Guifang Ouyang, Fanjun Meng, Yulu Tian, Yuemin Kuang, Fengping Zhou, Lixia Sheng, Weimei Jin, Gaixiang Xu, Liya Ma, Li Ye, Chen Mei, Jian Li, Jie Jin
Journal: Blood (2024)
Application of Stem Cell Boost for Immune Effector Cell Associated Hematotoxicity (ICAHT) Following BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Multiple Myeloma (MM)
Authors: Kritika Yadav, Tanvi H. Patel, Ramya Bachu, Jean Esselmann, Lisa E Rein, Aniko Szabo, Abhishek Janardan, Evanka Annyapu, Catherine E. Skoog, Areyl Goff, Othman Salim Akhtar, Samer Al Hadidi, Sharmilan Thanendrarajan, Maurizio Zangari, Nirav N. Shah, Frits van Rhee, Mehdi Hamadani, Binod Dhakal, Anita D'Souza, Meera Mohan, Carolina Schinke
Journal: Blood (2024)
Metabolic Tumor Volume after Two Cycles of Chemotherapy in Patients Treated for Advanced-Stage Hodgkin Lymphoma: Analysis of the German Hodgkin Study Group Phase III HD18 and HD21 Trials
Authors: Justin Ferdinandus, Helen Kaul, Gundolf Schneider, Michael Fuchs, Hans Theodor Eich, Christian Baues, Johannes Rosenbrock, Katrin S Roth, Alexander Drzezga, Lutz Van Heek, Markus Dietlein, Peter Borchmann, Carsten Kobe
Journal: Blood (2024)
Tucidinostat Plus Pediatric-Inspired Chemotherapy As First-Line Therapy for Newly Diagnosed ETP-ALL/Lbl: An Open-Label, Single-Arm, Phase 2 Trial
Authors: Jieping Lin, Chenhao Ding, Zicong Huang, Cai Zihong, Jia Li, Zhixiang Wang, Xiaofang Li, Xuan Zhou, Bailin He, Wenhao Zhong, Li Xuan, Qifa Liu, Yang Xu, Hongsheng Zhou
Journal: Blood (2024)
Tisagenlecleucel for the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: An Interim Report of the European Post-Authorisation Safety Study Conducted By EBMT
Authors: Silvia Montoto, Jurgen Kuball, Jarl E Mooyaart, Artak Ghandilyan, Dilyana Georgieva, Isabel Sánchez-Ortega, Chiara Bonini, Urban Novak, Dominik Schneidawind, Ibrahim Yakoub-Agha, Jakob Passweg, Nicolaus Kröger, Christian R Schultze-Florey, Barbara Dreta, Lucia Lopez Corral, Polina Stepensky, Paolo Corradini, Andrea Kuhnl, Stefania Bramanti, Carlos Solano, Ludovic Gabellier, Anja van Biezen, Annalisa Ruggeri, Bertram Glass, Christian Chabannon
Journal: Blood (2024)
Final Analysis of the Randomised UK MRA Myeloma XI+ Trial Examining Krdc (carfilzomib, lenalidomide, dexamethasone and cyclophosphamide) As Induction Therapy for Newly Diagnosed Multiple Myeloma Patients
Authors: Charlotte Pawlyn, Faith E Davies, Martin F Kaiser, Ruth M de Tute, Heather McIntyre, Jeanine Richards, Sharon Jackson, Elizabeth Hodson, Anna Hockaday, Catherine Olivier, John R Jones, Matthew W. Jenner, Gordon Cook, Walter Martin Gregory, Mark Drayson, Roger G Owen, Gareth Morgan, David A. Cairns, Graham Jackson
Journal: Blood (2024)
Oral Decitabine/Cedazuridine in Patients with MDS and <i>TP53</i> Mutations: A Propensity Score Matching Analysis from the Phase II and III Trials
Authors: Samuel Urrutia, Koji Sasaki, Alex Bataller, Hagop M. Kantarjian, Guillermo Montalban-Bravo, James McCloskey, Elizabeth A. Griffiths, Karen Yee, Amer M. Zeidan, Michael R. Savona, Aram Oganesian, Yuri Sano, Harold N. Keer, Guillermo Garcia-Manero
Journal: Blood (2024)
Motixafortide (CXCR4 Inhibition) Alone and in Combination with Natalizumab (VLA-4 Inhibition) As a Novel Regimen to Mobilize Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease: A First-in-Human, Proof-of-Principle Safety and Feasibility Study
Authors: Zachary D. Crees, Michael P. Rettig, Reyka G. Jayasinghe, Stephanie Christ, Feng Gao, Hailey Sappington, Sana Saif Ur Rehman, Suzanne R. Thibodeaux, Ella Sorani, Allison A. King, John F. DiPersio
Journal: Blood (2024)
5-Year Follow-up Analysis from ZUMA-5: A Phase 2 Trial of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Authors: Sattva S. Neelapu, Julio C. Chavez, Alison R. Sehgal, Narendranath Epperla, Matthew Ulrickson, Emmanuel Bachy, Pashna N. Munshi, Carla Casulo, David G. Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Olalekan O. Oluwole, Ibrahim Yakoub-Agha, Rashmi Khanal, Joseph D. Rosenblatt, Jacob Wulff, Rhine Shen, Wangshu Zhang, Soumya Poddar, Harry Miao, Olga Nikolajeva, Caron A. Jacobson
Journal: Blood (2024)
Multiple Myeloma Progression Is Accelerated By Microenvironmental-Derived Fatty Acid Binding Proteins 4 and 5 (FABP4/FABP5) in a Murine Model
Authors: Heather Fairfield, Haylee Duval, Kaitlyn Belknap, Katie Knox, Kehinde Abayomi, Sergey Ryzhov, Michaela R Reagan
Journal: Blood (2024)
A Phase II Randomized Trial Comparing Low-Dose Cytarabine and Venetoclax +/- Midostaurin in Non-Adverse Cytogenetic Risk Acute Myeloid Leukemia: The ALLG AMLM25 Intervene Trial
Authors: Chong Chyn Chua, Blake Hsu, Anoop K Enjeti, Ashish Bajel, Paula Marlton, Shaun Fleming, Devendra Hiwase, Chun Kei Kris Ma, Peter J. Browett, Travis Perera, Carolyn S. Grove, Shuhying Tan, Jad Othman, Julian Cooney, Hannah Rose, Edward S Morris, Rachel Koldej, David S. Ritchie, Kate Mason, Natasha S. Anstee, John Reynolds, Andrew H Wei
Journal: Blood (2024)
Prevalence and Clinical Impact of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Chronic Lymphocytic Leukemia and Richter Transformation
Authors: Chiara Cosentino, Samir Mouhssine, Mohammad Almasri, Ilaria Romano, Lodovico Terzi Di Bergamo, Jana Nabki, Luca Cividini, Bashar Al Deeban, Francesca Maiellaro, Abel Mehari Sium, Annalisa Gaglio, Francesca Perutelli, Valentina Griggio, Riccardo Dondolin, Matteo Bellia, Silvia Rasi, Eleonora Secomandi, Sreekar Kogila, Joseph Ghanej, Elisa Albi, Candida Vitale, Lydia Scarfo, Paolo Ghia, Marta Coscia, Valter Gattei, Antonella Zucchetto, Davide Rossi, Gianluca Gaidano, Riccardo Moia
Journal: Blood (2024)
Using Large-Scale Multiomic Datasets to Assess the Population Frequency of <i>ADAMTS13</i> Loss-of-Function Variants in the United States and United Kingdom
Authors: Amelia K Haj, Sean J. Jurgens, Xin Wang, Justine Ryu, Seung Hoan Choi, Patrick Ellinor, Pavan K Bendapudi
Journal: Blood (2024)
Preliminary Safety and Biomarker Results of the NLRP3 Inflammasome Inhibitor DFV890 in Adult Patients with Myeloid Diseases: A Phase 1b Study
Authors: Guillermo Garcia-Manero, Yasmin Abaza, Peter L. Greenberg, Tamanna Haque, Kyra Velázquez Kennedy, Matteo Giovanni Della Porta, Melissa G Ooi, Maximilian Stahl, Zhuoer Xie, Abhishek A. Mangaonkar, Pinkal Desai, Amy E. DeZern, Alice Garnier, Mathieu Meunier, Anna Maria Pelizzari, Uwe Platzbecker, Katja Sockel, Ashwin Kishtagari, Hongbo Lu, Luca Manganelli, Lexiang Ji, Zheng Yan, Yutong Li, Mike Roy, Ewa Gatlik, Arti Singh, Valerie Beaulieu, Marc Pelletier, Philipp Rauch, Harinder Gill
Journal: Blood (2024)
Genomic Subtypes of AML Define Sensitivity to NK Cell Cytotoxicity
Authors: Hanna Duàn, Emmi Jokinen, Hanna Lähteenmäki, Jay Klievink, Jonas Bouhlal, Essi Laajala, Jason Theodoropoulos, Heikki Kuusanmäki, Tanja Ruokoranta, Pauliina Rumm, Dean Anthony Lee, Esa Pitkänen, Tomi P Mäkelä, Kimmo Porkka, Oscar E. Brück, Olli Dufva, Satu Mustjoki
Journal: Blood (2024)
PET-Guided Brecadd in Older Patients with Advanced-Stage Classic Hodgkin Lymphoma: Results of the Phase 2 Part of the GHSG HD21 Trial
Authors: Justin Ferdinandus, Helen Kaul, Alexander Fosså, Andreas Hüttmann, Felix Keil, Yon-Dschun Ko, Felicitas Hitz, Michaela Schwarz, Corinna Trenker, Andrea Kerkhoff, Peter Staib, Kai Wille, Irmgard Dresel, Dennis Hahn, Bernd Hertenstein, Peter Moosmann, Ulrich Mey, Stefan Balabanov, Tasman Armytage, Fernando Roncolato, Johannes Christian Hellmuth, Stefanie Kreissl, Michael Fuchs, Gundolf Schneider, Hishan Tharmaseelan, Dennis A Eichenauer, Bastian von Tresckow, Peter Borchmann, Paul J. Bröckelmann
Journal: Blood (2024)
Outcomes of Blast-Phase MPN and <i>JAK2</i>, <i>MPL</i>, and <i>CALR</i> Mutated de Novo AML Compared to AML with Wild-Type <i>JAK2</i>, <i>MPL</i>, and <i>CALR</i> Genes: A Propensity Score-Adjusted Cohort Study
Authors: Daniel P. Nurse, Jessica El-Asmar, Ameed Bawwab, Yomna Abu-Farsakh, Moath Albliwi, John Hanna, Asad Rauf, Hasan Abuamsha, Heya Batah, Daniel Cancilla, Emily C. Zabor, Yohana B. Bedelu, Mark Jinan Chen, Joy Nakitandwe, Ismail Elbaz Younes, David S. Bosler, Akriti G. Jain, John C. Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Sudipto Mukherjee, Anjali S. Advani, Hetty E. Carraway, Moaath K. Mustafa Ali
Journal: Blood (2024)
B Cell Receptor Silencing Reveals Origin and Impacts Treatment of High-Grade B Cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
Authors: Stefano Casola, Paola Sindaco, Silvia Lonardi, Gabriele Varano, Ilaria Pietrini, Gaia Morello, Piera Balzarini, Hadas Neuman, Filippo Vit, Giorgio Bertolazzi, Hiroshi Arima, Marco Chiarini, Luisa Lorenzi, Vilma Pellegrini, Sabrina Giampaolo, Daniel Garzon, Cecilia Ranise, Mattia Bugatti, Chiara Pagani, Rosa Daffini, Federica Mainoldi, Viveka Selvarasa, Anojan Sivacegaram, Henry Yang, Li Ying, Valeria Cancila, Raoul Bonnal, Euplio Visco, Cristina Lopez Gonzalez, Pasquale Capaccio, Andrés José María Ferreri, Alessandra Tucci, Antonello Cabras, Giancarlo Pruneri, Arianna Di Napoli, Reiner Siebert, Riccardo Bomben, Brunangelo Falini, Marco Pizzi, Joo Y. Song, Wing Chung Chan, Maurilio Ponzoni, Ramit Mehr, Claudio Tripodo, Fabio Facchetti
Journal: Blood (2024)
Blinatumomab Added to Chemotherapy Improves Disease-Free Survival in Newly Diagnosed NCI Standard Risk Pediatric B-Acute Lymphoblastic Leukemia: Results from the Randomized Children's Oncology Group Study AALL1731
Authors: Rachel E. Rau, Sumit Gupta, John A. Kairalla, Karen R Rabin, Anne Angiolillo, Cindy Wang, Andrew J. Carroll, Susan Conway, Meenakshi Devidas, Lia Gore, Ilan R. Kirsch, Holly R. Kubaney, Amanda M Li, Jennifer L. McNeer, Olga Militano, Yvonne Moyer, Maureen M. O'Brien, Maki Okada, Shalini C. Reshmi, Mary Shago, Elizabeth R. Wagner, Naomi J. Winick, Brent L. Wood, Faraz Zaman, Gerhard Zugmaier, Sue Zupanec, Stephen P. Hunger, David T. Teachey, Elizabeth A. Raetz, Mignon L. Loh
Journal: Blood (2024)
PKMYT1 Kinase Is an Actionable Synthetically Lethal Target for Del17p Myeloma
Authors: Anais Schavgoulidze, Mariateresa Fulciniti, Giulia Giorgetti, Sabrina Maheo, Shuhui Deng, Vanessa Favasuli, Srikanth Talluri, Masood A. Shammas, Luka Pavageau, Anil Aktas-Samur, Mehmet K. Samur, Herve Avet-Loiseau, Jill Corre, Nikhil C. Munshi
Journal: Blood (2024)
Efficacy Findings in a Phase 3, Randomized Trial of Eltrombopag Vs. Standard First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia in Children
Authors: Kristin A. Shimano, Amanda B. Grimes, Melissa J Rose, Shipra Kaicker, Sanjay J. Shah, Michael Briones, Elizabeth Gunn, Taizo A. Nakano, Jeffrey D Lebensburger, Michele P. Lambert, Stephanie A. Fritch Lilla, Rohith Jesudas, Cathy A. Lee-Miller, Alexis Thompson, Rukhmi Bhat, Stacey Rifkin-Zenenberg, Suvankar Majumdar, Manpreet Kochhar, Shelley E Crary, Kerry Hege, Jennifer A. Rothman, James B. Ford, Joshua J Bies, John Fort, Loan Hsieh, Maritza E. Ruiz, Kathryn M. Carrier, Bogdan Dinu, Julia MW Wong, Pei-Chi Kao, Wendy B. London, Staci D. Arnold, Carolyn M. Bennett, Jenny Despotovic, Robert J. Klaassen, Ellis J. Neufeld, Cindy E Neunert, Rachael F. Grace
Journal: Blood (2024)
A Multiomic Analysis of Waldenstrom's Macroglobulinemia Identifies Three Subtypes of Disease Based on Impaired Plasma Cell Differentiation
Authors: Dylan C Gagler, Hussein Ghamlouch, Di Zhang, Patrick Blaney, Marine Armand, Alexandre Eeckhoutte, Amina Joudat, Michael Degaud, Michela Esposito, Gaurav Varma, Yubao Wang, Sanxiong Liu, Oscar B Lahoud, David Kaminetzsky, Marc J Braunstein, Florence Nguyen-Khac, Brian A. Walker, Damien Roos-Weil, Faith E Davies, Olivier Bernard, Gareth Morgan
Journal: Blood (2024)
Antiphospholipid Syndrome (APS) Is a Platelet Factor 4 (PF4)-Centric Immunothrombotic Disorder
Authors: Conroy O Field, Amrita Sarkar, Khalil Bdeir, Keith R. McCrae, Thomas L. Ortel, M. Anna Kowalska, Lubica Rauova, Douglas B. Cines, Kandace Gollomp, Mortimer Poncz
Journal: Blood (2024)
Update on GMALL Trial 08/2013 Shows Durable Favorable Outcome of Newly Diagnosed Adult Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL) with Imatinib, Dose-Reduced Induction Followed By Stem Cell Transplantation
Authors: Heike Pfeifer, Fabian Lang, Walter Fiedler, Matthias Stelljes, Folker Schneller, Björn Steffen, Boris Böll, Andreas Viardot, Christoph Faul, Lino L. Teichmann, Hendrik Poeck, Joerg Westermann, Kerstin Schäfer-Eckart, Thomas Heinicke, Thomas Burmeister, Stefan Schwartz, Monika Brueggemann, Hubert Serve, Nicola Goekbuget
Journal: Blood (2024)
Acute GvHD of the Gut Is Associated with Minor Histocompatibility Antigens Cross-Reactive Against Gut-Tropic Viral Epitopes
Authors: Nicoletta Cieri, Yiren Shao, Kaila Power, Vincent T. Ho, Jonathan Stevens, William J. Lane, Haesook T. Kim, Donna S. Neuberg, Chip Stewart, Gad Getz, Jerome Ritz, Robert J. Soiffer, Catherine J. Wu
Journal: Blood (2024)